Additionally, ceramide production, for which palmitate availability is a rate-limiting step, is well established to adversely affect cellular signalling pathways, including that of insulin, via activation of protein phosphatase 2 A [61] and is additionally linked to AD pathology [59]. The gene discussed is INS; the disease is Alzheimer disease.